Juan W. Valle/LinkedIn
Dec 19, 2024, 17:05
Juan W. Valle: ESMO updates BTC guidelines for advanced care
Juan W. Valle, Chief Medical Officer at Cholangiocarcinoma Foundation, posted the following on LinkedIn:
“The updated ESMO – European Society for Medical Oncology BTC Guidelines have just been released, reflecting significant advancements in the field. These changes mark critical progress in approaching the diagnosis and treatment of BTC, ensuring patients receive more personalized and effective care.
Key updates include:
- Molecular profiling/biomarker testing now recommended for locally advanced disease, not just metastatic disease.
- Radical treatment options added for patients unfit for surgery.
- Juan W. Valle, ESMO, BTC guidelines, biliary tract cancer, molecular profiling, biomarker testing, HER2-targeted therapies, zanidatamab, advanced cancer care, oncology advancements, oncology, cancer, oncodaily Inclusion of HER2-targeted therapies, including the newly approved zanidatamab.
View the updated treatment algorithm and guidelines.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 19, 2024, 17:05
Dec 19, 2024, 17:01
Dec 19, 2024, 16:53
Dec 19, 2024, 16:50
Dec 19, 2024, 16:42
Dec 19, 2024, 16:41
Dec 19, 2024, 16:12
Dec 19, 2024, 16:07